![Recruiting: Tetra Therapeutics Phase 3 Clinical Trial of Zatolmilast in Fragile X Syndrome • FRAXA Research Foundation - Finding a Cure for Fragile X Syndrome Recruiting: Tetra Therapeutics Phase 3 Clinical Trial of Zatolmilast in Fragile X Syndrome • FRAXA Research Foundation - Finding a Cure for Fragile X Syndrome](https://www.fraxa.org/wp-content/uploads/2024/02/Tetra-Therapeutics-Phase-3-Clinical-Trial-of-Zatolmilast-in-Fragile-X-Syndrome.png)
Recruiting: Tetra Therapeutics Phase 3 Clinical Trial of Zatolmilast in Fragile X Syndrome • FRAXA Research Foundation - Finding a Cure for Fragile X Syndrome
What is the average length of each phase of a clinical trial for drugs that eventually become approved by the FDA? - Quora
![Maximizing the Value of Phase III Trials in Immuno-Oncology - Society for Immunotherapy of Cancer (SITC) Maximizing the Value of Phase III Trials in Immuno-Oncology - Society for Immunotherapy of Cancer (SITC)](https://higherlogicdownload.s3.amazonaws.com/SITCANCER/2c19e5a6-3adb-4d01-b46c-c01e11745b3a/UploadedImages/MVP_Page/MVPfigure.png)